Hamill John

Co-President and CFO at SAVIENT PHARMACEUTICALS INC · on record since Oct 17, 2013
Chief Financial Officer at NephroGenex, Inc. · on record since Feb 10, 2014

Insider trading activity of Hamill John

Transactions on record: 14; since Sep 26, 2012

Open-market buys: 0

Open-market sells: 6; $3K

Companies traded: 2; last filing Nov 12, 2015

Figures computed from official regulatory filings — .

Companies where Hamill John has traded

NephroGenex, Inc.5 tx · Nov 12, 2015
SAVIENT PHARMACEUTICALS INC9 tx · $1M · Oct 17, 2013

Track record of Hamill John

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hamill John

Co-insiders of Hamill John

Baetz Cary DSAVIENT PHARMACEUTICALS INC
Bahrt KennethSAVIENT PHARMACEUTICALS INC
Blanchard KarlSAVIENT PHARMACEUTICALS INC
Care Capital III LLCNephroGenex, Inc.
Care Capital Investments III L.P.NephroGenex, Inc.
Care Capital Offshore Investments III LPNephroGenex, Inc.
CLEMENT CHRISTOPHER GSAVIENT PHARMACEUTICALS INC
CONRAD HERBERT JSAVIENT PHARMACEUTICALS INC
Constantine GingerSAVIENT PHARMACEUTICALS INC
CROWLEY RichardSAVIENT PHARMACEUTICALS INC
DiPaolo Edward JohnSAVIENT PHARMACEUTICALS INC
FASS SIMCHASAVIENT PHARMACEUTICALS INC
FERRARI LOUISSAVIENT PHARMACEUTICALS INC
Fink David LSAVIENT PHARMACEUTICALS INC
Fox J. WesleyNephroGenex, Inc.
Gionco DavidSAVIENT PHARMACEUTICALS INC
Gutzeit GinaSAVIENT PHARMACEUTICALS INC
Gyenes Lawrence ASAVIENT PHARMACEUTICALS INC
Hamelin PaulSAVIENT PHARMACEUTICALS INC
Hannasch BrianNephroGenex, Inc.
HAYDEN BRIAN JSAVIENT PHARMACEUTICALS INC
HAYWARD SURRY JEREMYSAVIENT PHARMACEUTICALS INC
HELLER ALAN LSAVIENT PHARMACEUTICALS INC
HINCHMAN STEVEN BSAVIENT PHARMACEUTICALS INC
HOROWITZ ZEBULUN DSAVIENT PHARMACEUTICALS INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
NephroGenex, Inc.Listing unverified	Nov 12, 2015	Award	136,381	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	May 4, 2015	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	Dec 15, 2014	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	Aug 15, 2014	AwardD (derivative)	24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	May 16, 2014	AwardD (derivative)	30,769	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-800	0.08 USD	$64	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-21,000	0.08 USD	$1.7K	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-7,646	0.08 USD	$611.7	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-1,000	0.08 USD	$80	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-5,000	0.08 USD	$400	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-1,500	0.08 USD	$120	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Mar 7, 2013	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Sep 26, 2012	AwardD (derivative)	250,000	2.92 USD	$730K	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Sep 26, 2012	Award	100,000	2.92 USD	$292K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
NephroGenex, Inc.Listing unverified	Nov 12, 2015	Award	136,381	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	May 4, 2015	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	Dec 15, 2014	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	Aug 15, 2014	AwardD (derivative)	24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NephroGenex, Inc.Listing unverified	May 16, 2014	AwardD (derivative)	30,769	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-800	0.08 USD	$64	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-21,000	0.08 USD	$1.7K	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-7,646	0.08 USD	$611.7	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-1,000	0.08 USD	$80	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-5,000	0.08 USD	$400	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Oct 17, 2013	Sell	-1,500	0.08 USD	$120	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Mar 7, 2013	AwardD (derivative)	110,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Sep 26, 2012	AwardD (derivative)	250,000	2.92 USD	$730K	SEC
SAVIENT PHARMACEUTICALS INCListing unverified	Sep 26, 2012	Award	100,000	2.92 USD	$292K	SEC